Home » Newsletters » BioWorld

BioWorld

March 24, 1992

View Archived Issues

INTERFERON TRIALS ADVANCE TO HIV PATIENTS

FIRST BOSTON PICK BOOSTS CENTOCOR

TV COMMENTS BOOST QUIDEL SHARES

PROLEUKIN APPROVED IN FORMER U.S.S.R.

IMCLONE EXPLANDS TRIALS OF MELANOMA DRUG

AIDS THERAPY TRIALS 'SUGGEST' PROMISE

CHIRON T0 USE LIDAK SCID MICE IN HIV TEST

FDA PANEL GIVES PENTYDE A NEW SETBACK

APS REGAINS BULK OF JOINT VENTURE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.